(Q55062120)
Statements
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma. (English)
1 reference
Pau Abrisqueta
1 reference
Jennifer R Brown
1 reference
Matthew S Davids
1 reference
Jordi Rodon
1 reference
Siddha N Kasar
1 reference
Joanne Lager
1 reference
Jason Jiang
1 reference
Coumaran Egile
1 reference
Farrukh T Awan
1 reference
3 April 2015
1 reference
21
1 reference
14
1 reference
3160-3169
1 reference